Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

NCT02542007 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Arteriosclerosis

Interventions

DEVICE: OrbusNeich Combo stent™
DEVICE: sirolimus-eluting stent system

Sponsor

OrbusNeich

Collaborators

[object Object]
[object Object]